Related Experiment Videos
Carcinogenic effect of subcutaneously administered N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters
Abstract:
N-Nitroso-2,6-dimethylmorpholine (DMNM) was examined in Syrian golden hamsters in a comparative study of N-N-dipropylnitrosamine (DPN) metabolites. DMNM was administered sc, and the results were compared with those of a previous study in which the compound was given intragastrically. DMNM was more toxic when administered sc, and the respiratory tract was the main target organ (with a 100% tumor incidence). With an sc administration, neoplasms occurred earlier in the hamsters than with an intragastric administration, and fewer tumors of the pancreas and biliary tract were found. However, neoplasms of the upper digestive tract and vagina were seen only with sc treatment. These studies indicated the importance of the treatment route but did not substantiate the role of common metabolites, such as DMNM, formed by beta-oxidation from DPN, with regard to induction of a given tumor type.
Insights
The route of administration significantly impacts N-Nitroso-2,6-dimethylmorpholine (DMNM) toxicity and tumor development in hamsters. Subcutaneous DMNM exposure primarily targets the respiratory tract, leading to earlier tumor formation compared to intragastric administration.
Area of Science:
- Toxicology
- Carcinogenesis
- Experimental Pathology
Background:
- N-Nitroso-2,6-dimethylmorpholine (DMNM) is a chemical compound investigated for its carcinogenic potential.
- Understanding the metabolic pathways and target organs of carcinogens is crucial for risk assessment.
- N-N-dipropylnitrosamine (DPN) is a known carcinogen, and its metabolites are of interest.
Purpose of the Study:
- To compare the toxicity and carcinogenic effects of N-Nitroso-2,6-dimethylmorpholine (DMNM) when administered subcutaneously versus intragastrically in Syrian golden hamsters.
- To investigate the role of DMNM as a potential metabolite of N-N-dipropylnitrosamine (DPN) in tumor induction.
Main Methods:
- Syrian golden hamsters were administered DMNM via subcutaneous injection.
- Results were compared with a previous study using intragastric administration of DMNM.
- Tumor incidence, latency, and location were analyzed.
Main Results:
- Subcutaneous DMNM administration resulted in higher toxicity and a 100% tumor incidence in the respiratory tract.
- Neoplasms appeared earlier with subcutaneous administration compared to intragastric.
- Tumors of the upper digestive tract and vagina were exclusively observed with subcutaneous treatment, while pancreatic and biliary tumors were less frequent.
Conclusions:
- The route of administration critically influences DMNM's toxicological profile and target organ specificity.
- Subcutaneous administration of DMNM is a potent method for inducing respiratory tract tumors in hamsters.
- The study highlights the importance of administration route in carcinogenicity studies but does not confirm DMNM's role as a common beta-oxidation metabolite of DPN in specific tumor induction.